FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for treating unresectable or metastatic NSCLC.
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Cumberland Pharmaceuticals’ antibiotic Vibativ (telavancin) injection has gained approval from China’s National Medical ...
The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...
Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
A team of scientists has developed a new AI-based foundation model that can give insights into disease-causing mutations and ...
MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.
Biogen has entered a collaboration with Stoke Therapeutics to develop and commercialise zorevunersen to treat Dravet syndrome ...
Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing ...
The EC has conditionally approved MSD's Welireg as a single agent for the treatment of adults with VHL disease and advanced ...
As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results